Reich & Binstock
Free Initial Consultation
Toll Free: 877-643-3099
Local: 713-352-7883
877-643-3099 713-352-7883

April 2015 Archives

Fluoroquinolone drugs pose nerve damage risk

Since the U.S. Food and Drug Administration in August 2013 required fluoroquinolone drug labels to carry a warning about the risk of the possible rapid and permanent onset of peripheral neuropathy, a recent study showed that the risk is genuine. In the meantime, patients who were prescribed one of these medications and who were since diagnosed with peripheral neuropathy may want to discuss their legal options with an attorney - as many already have done.

Fluoroquinolone drugs pose nerve damage risk

Since the U.S. Food and Drug Administration in August 2013 required fluoroquinolone drug labels to carry a warning about the risk of the possible rapid and permanent onset of peripheral neuropathy, a recent study showed that the risk is genuine. In the meantime, patients who were prescribed one of these medications and who were since diagnosed with peripheral neuropathy may want to discuss their legal options with an attorney - as many already have done.

Drug labeling rule not much help to Zoloft victims

A new federal rule will go into effect June 30 that is designed to help health care providers to make the risk vs. benefit analysis consistent with prescribing medications for use during pregnancy and lactation. Maybe this measure would have helped a lot of women had it been implemented sooner. For, while reform is on the way, lawsuits are being filed by women nationwide who claim that their use of the antidepressant Zoloft (sertraline) during pregnancy is linked to their children's birth defects.

Drug labeling rule not much help to Zoloft victims

A new federal rule will go into effect June 30 that is designed to help health care providers to make the risk vs. benefit analysis consistent with prescribing medications for use during pregnancy and lactation. Maybe this measure would have helped a lot of women had it been implemented sooner. For, while reform is on the way, lawsuits are being filed by women nationwide who claim that their use of the antidepressant Zoloft (sertraline) during pregnancy is linked to their children's birth defects.

Xarelto victim alleges scientific data downplayed

The number of filed Xarelto lawsuits continues to grow primarily on two fronts. First, the Philadelphia Court of Common Pleas established a mass tort docket in January where more than 170 Xarelto lawsuits are pending. Second, a panel of federal judges centralized federal Xarelto lawsuits in December before the U.S. District Court for the Eastern District of Louisiana for uniform pretrial management. As of April 15, more than 400 Xarelto lawsuits were pending before the Louisiana federal trial court.

Xarelto victim alleges scientific data downplayed

The number of filed Xarelto lawsuits continues to grow primarily on two fronts. First, the Philadelphia Court of Common Pleas established a mass tort docket in January where more than 170 Xarelto lawsuits are pending. Second, a panel of federal judges centralized federal Xarelto lawsuits in December before the U.S. District Court for the Eastern District of Louisiana for uniform pretrial management. As of April 15, more than 400 Xarelto lawsuits were pending before the Louisiana federal trial court.

Zoloft lawsuits go to trial but still time to file

The reportedly first U.S. Zoloft birth defects lawsuit progressed to a jury trial in a Missouri state court earlier this month. Zoloft lawsuits have been filed in state and federal courts across the country. As of April 15, there were 548 such lawsuits centralized for pretrial management before the U.S. District Court for the Eastern District of Pennsylvania.

Zoloft lawsuits go to trial but still time to file

The reportedly first U.S. Zoloft birth defects lawsuit progressed to a jury trial in a Missouri state court earlier this month. Zoloft lawsuits have been filed in state and federal courts across the country. As of April 15, there were 548 such lawsuits centralized for pretrial management before the U.S. District Court for the Eastern District of Pennsylvania.

Trucks that do 85 in Texas could be a source of disaster

Folks who do a lot of driving between San Antonio and Austin may be aware of the 41-mile stretch of State Highway 130 that allows vehicles to tool along at 85 mph. What they may not know is that if they are sharing the road with one of the many tractor-trailers that use the route, they could be at increased risk of being involved in an accident.

Trucks that do 85 in Texas could be a source of disaster

Folks who do a lot of driving between San Antonio and Austin may be aware of the 41-mile stretch of State Highway 130 that allows vehicles to tool along at 85 mph. What they may not know is that if they are sharing the road with one of the many tractor-trailers that use the route, they could be at increased risk of being involved in an accident.

Risperdal victim awarded $2.5 million

Alabama native Austin Pledger started taking the antipsychotic Risperdal in 2002, when he was 8 years old, to treat autism symptoms. By the time he was a teenager, Pledger had been diagnosed with gynecomastia, the abnormal development of breasts in men. Reportedly, Pledger's breasts reached size 46DD. Instead of suffering in silence, the patient and his mother sought justice, as Risperdal clients of the law firm of Reich & Binstock also have done. And two months ago, a jury saw things Pledger's way.

Risperdal victim awarded $2.5 million

Alabama native Austin Pledger started taking the antipsychotic Risperdal in 2002, when he was 8 years old, to treat autism symptoms. By the time he was a teenager, Pledger had been diagnosed with gynecomastia, the abnormal development of breasts in men. Reportedly, Pledger's breasts reached size 46DD. Instead of suffering in silence, the patient and his mother sought justice, as Risperdal clients of the law firm of Reich & Binstock also have done. And two months ago, a jury saw things Pledger's way.

Zofran victims allege birth defects

Zofran lawsuits filed in numerous states contain serious allegations concerning an apparent link between an expectant mother's use of the "morning sickness" drug and the emergence of birth defects. Operating in all 50 states, attorneys with the Zofran Litigation Team at Reich & Binstock are taking cases from victims across the country.

Zofran victims allege birth defects

Zofran lawsuits filed in numerous states contain serious allegations concerning an apparent link between an expectant mother's use of the "morning sickness" drug and the emergence of birth defects. Operating in all 50 states, attorneys with the Zofran Litigation Team at Reich & Binstock are taking cases from victims across the country.

Discount store toys may be cheap, but may also be deadly

The world is not a bastion of safety. No matter how much effort a caring parent may take to try to be sure their children avoid injury, there is no way to eliminate every potential hazard. And, truth be told, everyone probably would have to admit that at some time or another they've seen a parent who didn't exercise even the smallest level of care on behalf of their children.

Discount store toys may be cheap, but may also be deadly

The world is not a bastion of safety. No matter how much effort a caring parent may take to try to be sure their children avoid injury, there is no way to eliminate every potential hazard. And, truth be told, everyone probably would have to admit that at some time or another they've seen a parent who didn't exercise even the smallest level of care on behalf of their children.

Potential Xarelto antidote good news but late for some

There is encouraging news, albeit tardy to some of us, in regard to minimizing the risk of uncontrollable bleeding linked to the use of the blood thinner Xarelto (rivaroxaban). As hundreds of Xarelto lawsuits are pending in U.S. courts, a pharmaceutical company believes it is close to developing an antidote which may ameliorate the severe bleeding risk.

FDA proposes greater cooperation with its 'stakeholders'

There must be ways that federal regulators and their external "stakeholders" can collaborate on projects that can help to ensure the safety of pharmaceutical products. The U.S. Food and Drug Administration, which appears to believe so, wants to tap into a reservoir of external scientific research to meet its regulatory needs.

FDA proposes greater cooperation with its 'stakeholders'

There must be ways that federal regulators and their external "stakeholders" can collaborate on projects that can help to ensure the safety of pharmaceutical products. The U.S. Food and Drug Administration, which appears to believe so, wants to tap into a reservoir of external scientific research to meet its regulatory needs.

Contact Us

Contact Us For Legal Advice

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Map & Directions